Nicotine induced haemodynamic changes during cigarette smoking and nicotine gum chewing: A placebo controlled study in young healthy volunteers

Cardiovascular Research

Volumn 22, Issue 2, 1988, Pages 154-158

  Bounameaux, Henri ^a   Griessen, Marthe ^a   Benedet, Pia ^a   Krahenbuhl, Bernard ^a   Deom, André ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Blood pressure; Cigarette; Nicotine; Nicotine gum; Peripheral vascular resistance; Tachycardia

Indexed keywords

NICOTINE;

ADULT; CHEWING GUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; SMOKING; VASOCONSTRICTION;

ADULT; BLOOD PRESSURE; CHEWING GUM; COMPARATIVE STUDY; FINGERS; HEART RATE; HUMAN; MALE; NICOTINE; REGIONAL BLOOD FLOW; SMOKING;

EID: 85047675177     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/22.2.154     Document Type: Review

References (17)

1. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.
2. da Silva A, Widraer LK. Peripher-arterielle Verschlusskrankheit. In: Widmer LK, Stähelin HB, Nissen C, da Silva A, eds. Venen-Arterien-Krankheiten, koronare Herzkrankheit bei Berufstätigen (Basler-Studie I-III), Bern: Hans Huber Verlag, 1981: 137-237.
3. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-7.
4. Levine PH. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation 1973;48:619-23.
5. Wennmalm A. Effects of nicotine on cardiac prostaglandin and platelet thromboxane synthesis. Br J Pharmacol 1978;64:559-63.
6. Wennmalm A. Nicotine inhibits hypoxia and arachidonate-induced release of prostacyclin-like activity in rabbit hearts. Br J Pharmacol 1980;69:545-9.
7. Kannel WB. Update on the role of cigarette smoking in coronary artery disease. Am Heart J 1981;101:319-28.
8. Louis TA, Lavori PW, Bailar JC III, Polansky M. Crossover and self-controlled designs in clinical research. N Engl J Med 1984;310:23-31.
9. Bennett T, Hosking DJ, Hamton JR. Cardiovascular responses to lower body negative pressure in normal subjects and in patients with diabetes mellitus. Cardiovasc Res 1979;13:31-8.
10. 2). Method and application in perinatal medicine. J Perinal Med 1973;1:183-91.
11. Hengen N, Hengen M. Gaz-liquid chromatographic determination of nicotine in plasma. Clin Chem 1978;24:50-3.
12. 2 and prostacyclin do not modulate the systemic hemodynamic response to cold in humans. J Lab Clin Med 1985;106:534-41.
13. Russel MAH, Jarvis MJ, West RJ, Feyerabend C. Buccal absorption of nicotine from smokeless tobacco sachets. Lancet 1985;2:1370
14. Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986;73:662-7.
15. Heyndrickx GR, Boettcher DH, Vatner SF. Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Phvsiol 1976;231:1579-87.
16. Nicod P, Winniford MD, Campbell WB, Rehr RB. Firth BG, Hillis LD Alterations in coronary blood flow induced by cigarette smoking: lack of relation to plasma arginine vasopressin concentrations. Am J Cardiol 1984;54:667-8.
17. Sonnenfeld T. Wennmalm A. Inhibition by nicotine of the formation of prostacyclin-like activity in rabbit and human vascular tissue. Br J Pharmacol 1980;71:609-13.